Review Article
Nepal Med Coll J 2008; 10(1): 48-63
Fungal infections of the eye - laboratory diagnosis and treatment
N Nayak
Corresponding author: Additional Professor of Ocular Microbiology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India
Institute of Medical Sciences, New Delhi–110029, India. e-mail: niruni2000@yahoo.com
ABSTRACT
Infections of the eye give rise to severe ocular morbidity and blindness include keratitis, orbital cellulites,
endophthalmitis and dacryocystitis. Corneal blindness, in developing countries is predominantly associated
with infections. In India, nearly 30-35% of all culture positive infectious keratitis are caused fungi. Laboratory
diagnosis mainly depends upon proper collection and transport of clinical specimens. In fungal keratitis, corneal
scraping is the ideal sample, but occasionally corneal biopsy or anterior chamber aspirate may also be needed.
Corneal scraping is usually by Kimura spatula, under a slit lamp examination, after anaesthetizing the cornea
with topical anaesthetic like 0.4% proparcaine. Corneal biopsy is done by a minor trephining and AC aspirate
using a sterile tuberculin syringe. In case of endophthalmitis, 150-200ìl of aqueous humour is collected.
Vitreous fluid (500-1000 ìl), however, is collected by pars plana vitrectomy onto sterile tuberculin syringe, the
needle is then fixed to a sterile rubber bung after expelling air from the syringe. The collected sample is
immediately transported to the laboratory. Swabs from the regurgitating lacrimnal sacs and wound aspirate/
swabs are the ideal specimens for dacryocystitis and orbital cellulites, respectively. These samples are cultured
onto SDA slants following standard procedures. The main draw back of culture is its long incubation time (5 to
14 days), though it is indispensable from the view point of the specificity. Direct examination (KOH wet
mount, Gram’s, Giemsa or calcofluor fluorescent staining methods) of the specimen, however, is quick and
immensely helpful for ophthalmologist. The newer rapid methods, such as molecular techniques are also available
and the management of patients can be according to the results obtained. With the advent of novel antifungal
agents such as newer azoles and cell wall acting antifungals like echinocandins, the clinician has the wider
option of selecting the therapeutic modality. In the event of the increasing reports of in vitro drug resistance to
much frequently used azoles, polyenes and 5-fluorocytosines, clinical applicability of the newer antifungal
agents seems to be quite promising.
Keywords: Fungal eye infections, orbital cellulites, dacryocystitis, endophthalmitis, keratitis, antifungal agents.
Predisposing factors
Mycotic keratitis in the tropical and subtropical zones
is largely due to filamentous fungi, although yeasts,
particularly Candida may also be responsible in a small
percentage of cases.3 The most common predisposing
factor is trauma to the eye with vegetative matter. In
such cases, the history elicited from the patients is quite
suggestive of fungal infection. Usually a healthy young
adult male engaged in agricultural or outdoor work often
gets traumatized in the eye with some kind of vegetative
matter and he develops an ulcerative lesion 10-15 days
following injury. In a series of recently conducted studies
it was observed that trauma could predispose to
ulcerative keratitis in 23-55% of cases.4,5,9-11
Fungal infections of the eye are important amongst the
clinical conditions responsible for ocular morbidity and
blindness. In tropical countries, including India, keratitis
is the most frequently encountered fungal infection,1
although the orbit, lids, lacrimal apparatus, sclera,
conjunctiva and intra-ocular structures may also be
involved. In the present review, discussion will mainly
be focused on the most important clinical entities like
(a) keratomycosis, (b) endophthalmitis, (c) orbital
cellulitis with a very brief overview of dacryocystitis.
KERATOMYCOSIS
Fungal infection of the cornea (keratomycosis, mycotic
keratitis or fungal keratitis) was described for the first
time by Leber2 in Germany in the year 1879. Since then
it has been recognised as a major public health problem
in the tropical parts of many developing nations
including India.3-5 Corneal infection of fungal etiology
may represent 40-50% of all cases of culture proven
infectious keratitis.3,6 If not treated early, this condition
may lead to corneal blindness. In contrast to this, the
figures in western countries are variable. Whereas
Keyhani et al 7 reported 0.6% of fungal infection
following penetrating keratoplasty, Harris et al8 reported
25% of keratitis due to Candida albicans following the
same procedure.
Seasonal variations are known to affect the frequency
of isolation and types of fungi.12 Other conditions include
prior administration of corticosteroids and long term use
of antibiotics.10,11 The use of hydrogel contact lenses has
also been associated with fungal keratitis.3 For keratitis
caused by yeasts, however, three important risk factors
such as chronic ocular surface disease, contact lens wear
and use of topical steroids are associated.14 Recent
investigations suggested the association of contact lens
solution in the induction of Fusarium keratitis.13 Males
are significantly more frequently affected than females,
48
N Nayak
presumably because of trauma encountered by them at
a higher frequency during outdoor activities. 15 In
addition, other less frequently associated conditions
include previous episode of keratitis, surgery,
malnutrition, dry eye and facial palsy.8,9
Pathogenesis
Invariably, fungi are not able to penetrate the intact
corneal epithelium, unless the eye is severely
immunocompromised due to long term use of antibiotics
or steroids or due to any other predisposing conditions.20
Trauma facilitates the penetration of the fungal inoculum
deep into the layers of the cornea, even up to the stroma.
Fungi being ubiquitous, trauma due to vegetative or
organic matter helps in the diposition of spores on the
injured cornea which acts as a very good substrate for
the spores to germinate and give rise to hyphae.20,21 The
hyphal forms being invasive, can traverse through the
stroma and reach the Descemet’s membrane producing
descemetocele. Even infection can reach and penetrate
Descemets without producing a descemetocle which
involves loss of all stromal tissues. There can be
perforation of the entire cornea and the organism can
reach the anterior chamber, giving rise to hypopyon. At
Common etiological agents
Many fungal genera have been implicated in
keratomycosis, the most frequently isolated being,
Aspergillus, Fusarium, Curvularia, Helminthosporium,
Alternaria, Penicillium and Bipolaris species.
According to the published literature,8,9 more than 56
genera of fungi, comprising of over 100 species have
been incriminated as the causative agents of mycotic
keratitis. A careful review of the literature shows the
role of various fungal isolates in causing keratomycosis
throughout the world, with differing predominant risk
factors (Table-1).4,5,10,11,14.16-19
Table-1: Major risk factors and etiological agents of mycotic keratitis
Risk Factors (% of total)
Isolates (% of total isolates)
Reference (place of study)
Trauma (35)
Trauma (55)
Systemic illness (11.1)
Previous eye surgery (18.5)
Contact lenses (3)
Aspergillus (25), Fusarium
(6.4)
Aspergillus spp. (39.5)
Fusarium spp. (14)
Alternaria spp. (10.2)
Curvularia spp (7.4)
Penicillium spp. 97)
Candida albicans (45.8)
Fusarium (25)
Ref. 4 (Sri Lanka)
Ref. 10 (India)
Ocular Surface disorder (41.7)
Contact lens wear (29.2)
Atopic disease 916.7)
Ocular trauma (0.3)
Topical steroids (16.7)
Trauma (44)
Topical medication (13)
Diabetes (12)
Topical steroids (7)
Contact lens (6)
Trauma (39.2)
Trauma (65.4)
Corticosteroids (8)
Traditional eye remedies (37)
Trauma (42)
Contact lens wear (25)
Topical steroids (21)
Trauma (50)
Trauma (82.9)
Topical steroids (19.3)
Ref. 14 (Philadelphia)
Ref. 11 (Florida)
Fusarium spp (68)
Candida spp (14)
Curvularia spp (9)
Aspergillus spp (4)
Paecilomyces (3)
Fusarium spp (52)
Aspergillus (15)
Cladosporium (6)
Fusarium spp (43)
Aspergillus spp(15)
Curvularis spp(3)
Aspergillus spp (41)
Curvularia spp (29)
Ref. 5 (Ghana)
Ref. 16 (India)
Ref. 17 (India)
Ref. 18 (Paraguay)
Acremonium spp (40)
Fusarium spp (15)
Aspergillus spp (59.8)
Fusrium spp (21.2)
49
Ref. 19 (India)
Nepal Medical College Journal
Table-2: Antifungal regime for keratomycosis
Yeasts: First choice: Amphotericin B
0.15% eye drops; Fluconazole(0.5%
drops, 200mg orally)
Alternatives: Flucytocine(1% drops,150mg/kg orally); Miconazole
1% drops,subcunjunctival/injection; Ketoconazole 1% drops;
Ketoconazole 200mg BD orally
Filamentous fungi: First choice:
Natamycin 5% drops
Alternatives: Amphotericin B 0.15% drops + FlucytosineItraconazole
(1% cream + 200-400 mg orally)
ulcer. Collection of a mere corneal swab is not
recommended. Use of a calcium alginate swab is
sometimes advised for better yield of fungus.27 However,
its utility is still debatable.
times one can even have a hypopyon without fungal
invasion of the anterior chamber.
Once, invasion occurs, the intrinsic virulence of fungi,
helps them to proliferate within the corneal tissue,
resisting the host defense and producing tissue damage.2
The large sizes of the hyphae of filamentous fungi and
the pseudohyphae of yeasts preclude complete ingestion
by macrophages and neutrophils. Toxins and enzymes
such as hemolysins, exotoxins and proteases, liberated
by the fungi contribute to the tissue damage, accentuated
further by the host inflammatory response.22,23
Corneal biopsy
It is a relatively invasive (trephining) procedure and
requires minor OT. The indications of biopsy are (a)
strong clinical suspicion of fungal keratitis (b) atleast
twice negative smear and culture report (c) no clinical
improvement on empiric antibiotic therapy. The biopsied
material is preferably removed enbloc. It is bisected,
half being sent to microbiology laboratory for
homogenization and culture and smear examination, and
the remaining half put in 10% buffered formalin for
histopathological examination.
Clinical features
The onset is usually insidious, often following corneal
injury. The ulcer often runs on indolent course. The
epithelium may show defect at the site of infiltration or
epithelial defect would have healed with deep stromal
infiltrates.24,25 Endothelial plaque with moderate degree
of hypopyon may be noticed.
Anterior chamber aspirate
Anterior chamber (AC) paracentesis is done when there
is strong clinical suspicion of intra ocular infection. In
addition, progressive corneal damage and persistent
hypopyon are also indicative of this procedure. The
aspirate is collected with the help of sterile tuberculin
syringe and 22 gauge needle. The AC is tapped via the
limbus. The needle should be removed before the
specimen is submitted in order to decrease the danger
to laboratory personnel. However, the nozzle of the
syringe should be sealed with a sterile rubber bung and
the whole set should be transported immediately to the
laboratory for processing.
The ulcer has a raised, wet, soft, creamy to greyish white
infiltrate. However, filamentous fungal infections are not
very wet until the case is well advanced. The ulcer has
feathery or hyphate margins and satellite lesions may
also be seen.24 The symptoms like pain, photophobia
and redness are more severe as compared to those seen
in bacterial keratitis. Features of keratitis due to C.
albicans and other yeasts resemble bacterial keratitis
with an overlying epithelial defect, a more descrete
infiltrate and slow progression. Such ulcers frequently
occur in eyes with preexisting corneal disease.26
Processing of samples
As a routine, the scraped out corneal tissue or the
biopsied material after homogenization is divided into
three portions, one for Gram staining, one for 10% KOH
wet mount and the third for culture. The reported rate of
utility (sensitivity) of simple KOH wet mount for the
presumptive diagnosis of fungal keratitis varies between
33 to 92%.28,29
Laboratory diagnosis
Once there is clinical suspicion of a fungal infection,
every effort should be made to recover the causative
fungus so that appropriate antifungal therapy may be
instituted timely. The various clinical samples, for
laboratory diagnosis, include (a) corneal scraping (b)
corneal biopsy and (c) anterior chamber aspirate.
Gram stain, though has been reported to yield an
accuracy of 60-75% in detecting the causative
organism,30 is undoubtedly a simple and rapid method.
A comparative evaluation on the efficacy of gram
staining of corneal scraping with hematoxylene and eosin
staining yielded a better diagnostic efficacy 22 as
compared to gram staining and KOH wet mount.31 Other
staining techniques like periodic acid schiff (PAS)
staining, Gomori’s methenamine silver staining,
calcofluor white, acridine orange, fluorescent stainings
have also been recommended.32
Corneal scraping
Scraping is collected after anaesthetising the cornea with
0.5% proparcaine drops and waiting for 2-3 minutes.
With the help of sterile Kimura spatula or Bard-Parker
blade No.15 or Iris repositor, scraping is done by
applying multiple, moderately firm, unidirectional
strokes, under slit lamp illumination. Material is
collected both from the base as well as from the edge of
the ulcer, after retracting the lids properly and after
cleaning any discharge or debris from the vicinity of the
50
N Nayak
Culture and identification: Apart from the conventional
culture techniques on SDA slants, and lactophenol cotton
blue (LCB) preparation of the growth for distinguishing
between yeasts and mycelia33 and for the identification
of mycelia fungi, one can also opt for a slide culture
technique33 which visualizes aerial hyphae of moulds
making the microscopic identification easier. Yeasts can
be speciated by looking for chlamydospore formation
on cornmeal agar and germ tube production as well as
various sugar fermentation and assimilation tests, urease
test and other biochemical tests.34
keratitis within a few hours, whereas culture takes at
least 5 to 6 days for a positive detection.36 In a recent
study,37 a PCR-based assay, developed to amplify a part
of the fungal 18S r-RNA gene, was used for detection
of fungal DNA in corneal scrapings. PCR and fungal
culture results matched in 74% of cases. Thus, PCR
assay, presently, seems quite promising for the diagnosis
of fungal keratitis, offering definite advantage over
culture methods. However, its main drawback is its
occasional false positivity that can be overcome by
application of stringency in laboratory procedures and
proper standardisation of the techniques, PCR remains
to be an effective method in diagnosing keratomycosis.
It is also a more sensitive and rapid method than the
conventional mycologic procedures. Besides, PCR is of
great benefit in rapidly detecting the presence of the
organism difficult to culture. The sensitivity of PCR,
taking culture as the gold standard, was quite high
between 89 to 94%, whereas, specificity ranged between
50% to 88%.36,37
Interpretation of culture report: Fungal spores being
ubiquitous, interpretation of fungal growth in the
laboratory is sometimes difficult. Moreover, the
causative agents of mycotic keratitis are often
saprophytic. Therefore, in order to attribute clinical
significance to a particular growth, the following criteria
need to be considered (1) the laboratory finding should
be correlated with clinical presentation, (2) inoculation
should be done on ‘C’ streak manner and growth
occurring only on the ‘C’ streak is considered significant,
(3) smear results should be consistent with culture, (4)
the same fungus should grow in more than one culture
medium and (5) the same organism should grow from
repeated scrapings.
Treatment of fungal keratitis
If direct microscopic examinations of corneal scrapes
or corneal biopsies yield definite results that are
consistent with the clinical picture, treatment should be
initiated immediately.3 The antifugnal agents available
today to combat fungal keratitis are not so well
developed as those available against bacterial infections.
Most of the available agents only inhibit the growth of
the fungus necessitating the host defense mechanisms
to eradicate the infection.38 The currently used antifungal
agents belong to, (1) Polyenes, (2) Azoles, including
newer azoles (3) Pyrimidines, (4) other derivatives
Molecular methods for the diagnosis of mycotic
keratitis: Polymerase chain reaction (PCR) assay, PCRSSCP (single stranded conformational polymorphism)
and PCR-RFLP (restriction fragment length
polymorphism) techniques have also been standardized
for fungal identification. 35 Of these, the PCR is
universally accepted as most popular technique as it can
yield quick results, confirming the diagnosis of mycotic
Polyenes: The polyene bind to the ergosterol of fungal
cell membrane, creating pores that disrupt the
homeostatic mechanisms leading to cell death. Nystatin
was the first polyene antifungal to be identified. It has
been recommended for topical use (100,000 units).
However, corneal toxicity and poor ocular penetration
limits its value.38
Table-3: Bacteria and fungi isolated from 86 eyes with
congenital dacryocystitis*
Bacteria
Fungi
Staph. epidermidis 28
Candida albicans
5
Str. pneumoniae
24
Aspergillus niger
5
Staph. aureus
6
Rhizopus sp.
3
Ps. aeruginosa
2
Aspergillus flavus 2
Enter. aerogenes
2
Penicillium sp
2
Proetus mirabilis
2
Alternaria sp
2
Esch coli
1
Phialophora sp
2
Acinetoebacter sp. 1
Trichoderma sp
2
Sterile
Drechslera sp
1
Curvularia sp
1
Mixed
1
20
Amongst polyenes, Natamycin is often the first drug of
choice for filamentous infections since it is easily
available. It is marketed as a 5% suspension for topical
use and has broad spectrum of activity. A 5% suspension
in the eye is well tolerated. However, this drug may be
ineffective in cases with deep stromal abscess because
of poor corneal penetration.38
Amphotericin-B has widely been used as a topical and
systemic drug for ocular infections. Preparation of a
0.15% suspension of Amphotericin B, reconstituted from
the 50mg vial power (for IV formulation) is universally
adopted for topical use as the first line drug both for
Candida keratitis as well as for keratitis due to other
mycelial fungi.14 After topical application, this drug can
penetrate deep into the corneal stroma and 0.15%
suspension is well tolerated, when istilled round the
*J Ocul Ther Surg 1985; 4: 54-7
51
Nepal Medical College Journal
Table-4: Organisms isolated from congenital dacyocystitis
(N=112)*
Bacterial
48 (42.9%) Fungal
6 (5.4%)
Coagulase neg.
Staphylococcus
24 (21.4%) Fusarium spp.
2 (1.8%)
Str. pneumoniae 14 (12.5%) Asp. niger
Ketoconazole is another imidazole with pharmacological
properties similar to that of miconazole; however, it is
less toxic and absorbable from the gastro-intestinal tract.
It is marketed as oral preparation in the form of 200mg
tablets. It can also be administered topically as 2% eye
drops. In earlier studies conducted on a rabbit models44,45
of keratitis it was found that there was effective intraocular penetration of ketoconazole after oral
administration. It was also reported in the literature that
this drug was quite effective both as a prophylactic and
a therapeutic agent when administered topically in an
A. flavus model of keratitis.46
1 (0.9%)
Stpah. aureus
3 (2.7%)
Helminthosporium sp. 1 (0.9%)
Diphtheroids
3 (2.7%)
Candida albicans
2 (1.8%)
Sterile
106 (94.6%)
Pseudomonas sp. 2 (1.8%)
usually reserved as a second-line drug in the
management of fungal keratitis.2
Streptococcus sp. 1 (0.9%)
Proteus sp.
1 (0.9%)
Sterile
64 (57.1%)
Fluconazole is a triazole compound, which can be
administered both systemically (200-400mg per day) and
topically (o.2% eye drops). After topical application, as
0.2% eye drop it shows good penetration into the anterior
chamber.47 The topical preparation is also well tolerated.
*Reference No. 84
clock every 15 to 30 minutes. However, intravenous
administration, with the recommended dosage, may
cause poor corneal bioavailabilitiy. The drug shows
nephrotoxicity after systemic administration.
Itraconazole is a newer triazole which has larger
spectrum of activity than fluconazole against filamentous
fungi.2 However, its only drawback is that it is quite
hydrophobic, and being 90% protein-bound in the serum,
does not penetrate the tissue as well as fluconazole does.
A series from India reported an effectivity rate of 69%
when topical or systemic itraconazole was used as the
sole therapy for keratomycosis.48
Fluorocytosine (Pyrimidines-5), a synthetic pyrimidine
analogue, is available in the form of 1% suspension for
topical use. It can be given orally (150mg/kg) as well. It
has synergistic effect with Amphotericin B. Its topical
form is nontoxic to the eye. If given systemically, it may
cause transient bone marrow depression and
gastrointestinal upset. The main drawback of this drug
is its limited spectrum of activity against filamentous
fungi and rapid development of resistance by Candida
species.39,40
Coad et al,49 on the basis of tube dilution minimal
inhibitory concentration and minimal fungicidal
concentration testing determined that the imidazoles
such as miconazole and ketoconazole consistantly
showed the lowest Geometric mean titre for filamentus
fungi. Thus, systemic azoles, in general have a good
penetration and are frequently used for fungal keratitis.
However, they have drug interactions and require
monitoring of liver function tests.
Azoles: These are the derivatives of imidazole ring with
substitution mainly in position 2. The imidazoles and
the structurally related N-substituted triazoles are
considered together because they share the same
antifungal spectrum and similar mechanism of action.
However, systemic triazoles have a longer half-life than
imidazoles. The imidazoles include clotrimazole,
miconazole and ketoconazole. The triazoles include
fluconazole and itraconazole.
Clotrimazole is usually used topically for skin and
genital Candida infections. It is marketed as a 1% lotion
for fungal dermatitis and as 1% cream for candida
vaginitis. A 1% vaginal cream placed into an ophthalmic
ointment container can be used for topical use in the
eye for the treatment of keratomycosis.
Newer azoles: Voriconazole is a new azole with broad
spectrum efficacy for fungal keratitis and
endophthalmitis. In a recent study,50 invitro susceptibility
of various fungal isolates in infectious keratitis towards
Voriconazole was 100%, Ketoconazole 82.4%,
Amphotericin-B 76.5%, Itraconazole 67%, Fluconazole
60% and 5-Fluorocytocin 60%. Voriconazole MIC (90)
was lowest for Candida species (0.016 mg/ml). They
concluded that voriconazole was a better alternative for
the therapeutic management of Candida and Aspergilus
ocular infections, as compared to other antifungal.
Miconazole can be used as 1% eye drop, or through
systemic infusion (20mg/kg body weight).41 The 1%
topical application is well tolerated and is reported to be
quite successful in treating keratomycosis due to
Aspergillus and Candida species42. A perspective series
from India43 found that it was effective in 64.7% of the
cases when administered topically every 2 hours. It is
Topical voriconazole was tested in rabbit models of
fungal keratitis. Sponsel et al, 51 tested topical
voriconazole in such a model of Paecilomyces induced
keratitis. It was their observation that voriconazole
therapy caused lesions to decrease within 8 days. Hyphal
masses were present in the control infected eyes (not
treated with the drug), but absent in the treated infected
52
N Nayak
eyes (as observed after sacrificing the animals and
examining the sections of the eye ball). In their opinion,
topical voriconazole is a good and effective alternative
to topical Amphotericin-B, because Paecilomyces
species are often resistant to Amphotericin B.
indicate that fungal infection has been eradicated, since
there may be active proliferation of the fungi deep in
the stroma; hence therapy should be continued for at
least 6 weeks, depending upon the antifungal agent
selected (Table-2).
In yet another development, Ozbek et al,52 emphasised
the role of voriconazole in the management of Alternaria
keratiits.In this study, they reported a case of a 69 year
old man with a history of corneal foreign body removal,
who developed a stromal infiltrate two months later. The
condition did not improve despite topical antibiotics and
natamycin. Repeat culture revealed Alternaria species,
and topical Amphotericin-B was started. When there was
no response, treatment was switched over to oral and
topical voriconazole. Steady resolution was noted within
ten days of therapy. Thus, they advocated that,
voniconazole provided clinical improvement of keratitis
due to Alternatia, which was earlier unresponsive to
Amphotericin B.
Patients with deep stromal infections and those who have
received corticosteroids appear to respond poorly to
medical therapy.55 Surgery may be necessary in such
cases. Every attempt is made, however, to prolong
medical therapy for as long as possible, since this renders
the infecting fungus nonviable, thereby improving the
outcome of surgery. At the same time surgery may help
medical management by increasing drug penetration.For
example, in small superficial corneal fungal infections,
regular surgical debridemet of the base of the ulcer helps
elimination of fungi and necrotic material, facilitating
the penetration of antifungal drugs into the corneal
stroma.3
Surgery also helps in supporting the globe, where
integrity of the globe is threatened as in case of thinnng
or perforation of the cornea. If there is persistent
epithelial defect, the usual recommendtion is a superficial
lamellar keratectomy with removal of necrotic stroma
and placing a thin conjunctival flap over the ulcerated
site.3 Blood vessels present on the conjunctival flap help
in rapid healing of the ulcer. Recently, Kim et al 56
reported amniotic membrane transplantation as a good
alternative for successful healing of corneal ulcers
refractory to medical management.
Other derivatives: Echinocandins: These drugs have
recently emerged as valuable antifungal agents. These
are cell wall acting agents unlike Amphotericin-B which
acts on fungal cell membranes. These drugs inhibit B 13 glucan synthesis, and include Caspofungin and
Micafungin. Recently, topical Caspofungin was tried in
a rabbit model53, in which a 0.5% suspension of the drug
was found to be as effective as 0.15% Amphotericin-B,
in the treatment of keratitis caused by Candida.
Povidone-iodine (Betadine) and Polyhexamethyl
biguanide (PHMB): The effectiveness of Povodoneiodine and PHMB as topical antifungals was evaluated
by a study group in India54 in experimentally induced
Aspergillus fumigatus keratitis in rabbits. Keratitis was
induced by corneal intrastromal infection of spores of
A. fumigatus in four groups of six healthy rabbits each.
Drugs used were 5% Natamycin, 0.02% PHMB, 1%
Betadine and 0.5% hydroxypropyl methyl celllulose
(HPMC) as control. The average healing time of ulcers
were 21.5 ±3.08 days for Natamycin, 27.8±2.28 days
for PHMB, 36.4±2.57days for Betadine and 38.2±4.7
for HPMC. While no corneal perforation occurred with
Natamycin therapy, there was one perforation case with
PHMB, there with Betadine and 5 with HPMC. Thus,
1% Betadine was not effective in fungal keratitis while
PHMB 0.02% was moderately effective.
However, in situations where there is keratitis with deep
stromal lesions or progressive keratitis with corneal
perforation not responding to antifungal treatment, a
penetrating keratoplasty38 is recommended. In this
procedure, at least 0.5mm of clear corneal tissue is
excised all around the infected area in order to decrease
the chances of recurrence.
The advantage of this procedure includes the elimination
of fungi simultaneously with the secondary inflammatory
reaction. Topical treatment with antimycotics is
recommended for several days post- operatively. An
alternative therapy may be the use of excimer laser at
193 nm.57
Influence of fungal species on clinical presentation,
therapeutic management and outcome of infection
Therefore, the overall view on the management of
mycotic keratitis is that the condition responds slowly
over a period of weeks to antifungal therapy. Thus, in
order to evaluate the prognosis, clinical signs of
improvement should carefully be noted; these include
deminution of pain, decrease in the size of the infiltrate,
disappearance of satellite lesions, rounding of the
feathery margins of the ulcer and hyperplastic masses
or fibrous sheets in the region of healing fungal lesions3.
Negative scrapings during treatment do not always
Although most cases of mycotic keratitis exhibit the basic
clinical features enumerated earlier, there may be certain
unique features, depending upon the aetiological agent.
In general, keratitis caused by filamentous fungi may
involve any part of the cornea with firm elevated slough,
hyphate lines extending from the ulcer margin, granular
infiltrates and satellite lesions.3 An endothelial plaque
and hypopyon may be seen 5 to 6 days.55 However,
considering particularly about certain common agents
causing mycotic keratitis, one would surely appreciate
53
Nepal Medical College Journal
Table-5: Organisms isolated from regurgitated materials in
acquired dacryocystitis (N=110)*
Bacteria
37 (33.5%) Fungus
Coagulase neg.
Staphylococcus
19 (17.3%) Fusarium sp. 2 (1.8%)
Str. pneumoniae
3 (2.7%)
Asp. niger
Staph. aureus
5 (4.5%)
Curvularia sp. 1 (0.9%)
Diphtheroids
3 (2.7%)
Alternaria sp 1 (0.9%)
Pseudomonas sp.
3 (2.7%)
Sterile
Streptococcus sp.
1 (0.9%)
Proteus sp.
1 (0.9%)
Alkaligenes sp.
1 (0.9%)
Acinetobacter sp.
1 (0.9%)
Sterile
73 (66.5%)
interpretation of antifungal susceptibility test results
which shows variability from laboratory to laboratory.
This is mainly due to lack of standardization of different
variables of this test, such as incubation temperature,
incubation time, inoculum size and composition of test
media63, and more so the establishment of the breakpoint
value for antifungal resistance. As for example, the
investigators in a recently conducted study64 could not
take the CLSI (Clinical and Laboratory Standards
Institute) breakpoint values into consideration for the
interpretation of EUCAST (European Committee on
Antibiotic Susceptibility Testing) MIC data.
5 (4.5%)
1 (0.9%)
105 (95.5%)
However, some progress has been made in this field
during the past decade with the standardisation of various
parameters of antifungal sensitivity testing. The methods
currently recommended by CLSI (M38 A,M 27A
documents) have been adopted by many laboratories for
the standardization of the techniques both for filamentous
fungi and yeasts and reproducibility of the results have
been claimed.63-66
A recent study,based upon such testing, documented the
superiority of Voriconazole over Itraconazole towards
Fluconazole resistant Candida isolates. Thus, antifungal
drug sensitivity testing in a routine laboratory could help
the clinician in prescribing drugs which are effective
against a particular clinical isolate, rather than putting
the patient on empirical therapy without knowing
whether the patient is going to respond to the prescribed
treatment or not. In this context, the results of a recent
study67 are noteworthy. While studying on the risk factors
and treatment outcome in fungal keratitis the authors
highlighted the importance of selecting the appropriate
antifungal agent particularly for patients who were
refractory to the primary therapy.67 In addition to this
there are scanty reports of inadequetly treated fungal
keratitis (becuause the sensitivity pattern was not known)
leading to serious complications like endophthalmitis.68
All the above mentioned observations only point towards
one thing that antifungal susceptibility testing is a
prerequisite in the management of all problematic
clinical situations mentioned above.
*Reference No. 84
that the most common fungi like Fusarium species
produce very severe infection with rapid onset of
perforation of the cornea. Vision may be completely lost
if timely therapeutic intervention is not initiated.58,59 The
same is true for Aspergillus flavus infection. Both these
agents produce toxins and extracellular enzymes like
proteinases. Some studies6,60 revealed that corneal
infections due to Aspergilli and Fusarium species are
so severe that, in addition to the signs and symptoms
mentioned above, around 42-60% of those may lead to
malignant glaucoma. In most of the cases the features
is so severe, that therapeutic keratoplasty is often
indicated. Infection due to certain dematiaceous fungi
(Curvularia or Bipolaris) is presented with persistent,
low grade, smouldering type of keratitis with minimal
structural alterations. Not infrequently, the necrotic
slough may be pigmented. However, complication like
perforation is less likely unless the cases is properly
managed or augmented by steroids.55 Pseudallescheria
boydii is another mycelial fungus which often gives rise
to severe form of keratitis with very poor clinical
improvement, in spite of all possible medical therapy
and may thus require surgical intervention.61,62 In contrast
to the features of certain difficult filamentous fungal
infections enumerated above, the stromal keratitis due
to yeasts quite often resembles bacterial keratiits3 and
thus can usually be managed with recommended
antifungals.
ORBITAL CELLULITIS
Orbital cellulitis is an infection of the soft tissue
surrounding the orbit. Orbital cellulitis of fungal origin
is the most serious ocular infection with significant
potential morbidity, including loss of vision, cavernous
sinus thrombosis, intracranial spread of infection and
occasionally death.60,69 Therefore, it is essential that
patients with peri-orbital infection need careful
evaluation and treatment. For this, study of anatomy of
the orbit and its adjascent structures and the
pathophysiology is essential.
Considering the aforementioned clinical situations,
therapy of such cases always remains a challenge before
the treating Ophthalmologist52 and thus, testing for
antifungal drug susceptibility seems to be a suitable
solution to this.60,62
Anatomy of the orbit and pathophysiology
Several anatomic features include, the thin and compliant
nature of the eyelid; the proximity of the orbit to the
paranasal sinuses, nasolacrimal apparatus, and the teeth;
However, there is always an ambiguity in the
54
N Nayak
and haematogenous communications through a valveless
venous system, between the orbit and the surrounding
facial compartments, especially the paranasal sinuses.70
permit a pre-septal infection to spread posteriorly into
the orbit.
Etiological agents and their pathogenicity
The most important and life threatening clinical entity
is acute rhino-cerebro-orbital-zygomycosis (RCOZ).
Mucor species are more frequently involved than the
other genera of the order Mocorles, (Rhizopus,
Rhizomucor and Absidia).72,73 Recent reports of the
thermophilic fungus Apophysomyces elegans,74 causing
invasive fungal infection like orbital cellulitis, suggests
that the property of angio-invasiveness of these fungi
accounts for their pathogenicity. Besides, Aspergilus
species like A. flavus, A. niger, A. fumigatus can also
invade vascular structures and thus can devastate orbital
structures by spreading from their primary site of
infection i.e. sinus. In addition to the above mechanisms,
Mucorales group of organisms, especially Mucor species
produce ketoreductase enzyme, which helps them to
thrive in the host, who is invariably diabetic and ketoacidotic.73 Even neutrophil dysfunction induced by
diabetic ketoacidosis, further accentuates the fungal
pathogenicity.75 Other putative host factors, which
augment the spread of the pathogen and in the
detorioration of the condition especially that of RCOZ
include neutropenia during chemotherapy,
immunosuppression (organ transplantation, prolonged
corticosteroids therapy, hemodialysis, malnutrition,
intra-venous drug abuse, leukaemia, aplastic anemia,
myelodysplastic syndrome, severe burns and long term
antibiotic use).75
Pre-septal cellulitis is the term given to inflammation
confined to the space anterior to the orbital septum.
Orbital septum is an extension of the periorbita
(periosteum of the orbital bone). The septum arises from
the orbital rim and inserts into the lower border of the
tarsal plate inferiorly and into the levator aponeurosis
superiorly. Thus, the orbit is delimited anteriorly by the
orbital septum, which is generally an effective barrier
that prevents spread of infection from the eyelids into
the orbit. Therefore, in pre-septal cellulitis, severe signs
of orbital disease such as proptosis, ophthalmoplegia and
visual loss are absent. Because of the loose and elastic
connective tissue attachments between the eyelid skin
and the underlying structures, the degree of swelling of
the eyelids is quite remarkable.
In contrast to this, the picture in postseptal cellulits is
different. The periosteum of the orbit (periorbita) is very
tightly attached to the suture lines and the orbital rims,
but more loosely adherent to the underlying bone
elsewhere. For this reason, infection spreading directly
from the sinuses to the orbit usually takes the form of a
subperiosteal abscess. The pre-septal cellulitis usually
occurs in the following manner69,71 (1) secondary to
localised infection or inflammation of the eyelids or
adjascent structures including hordeola, accute chalazia,
acute dacryocystitis, impetigo, herpetic blepharitis or
severe conjunctivitis, (2) secondary to eyelid or facial
trauma and (3) in patients with a recent history of upper
respiratory tract infection. The mechanism of post-septal
cellulitis is, however, totally different. The thin porous
bony wall of the orbit is surrounded by the paranasal
sinuses. Medially, the lamina papyracia of the ethmoidal
bone is less than 0.5mm thick.60 It is easily fractured in
response to direct or indirect trauma, and, frequently
there are congenital dehescenses in the bone, permitting
communications between the ethmoidal sinus and the
orbit. Infection may also spread from the ethmoidal
sinuses to the orbit via foramina through which the
ehmoidal arteries pass. Lastly, the venous drainage of
the orbit occurs posteriorly via the superior and inferior
ophthalmic veins, which traverse the superior orbital
fissure and empty into the cavernous sinus. The
ophthalmic and ethmoidal veins communicate directly.
Because, these communicating veins are valveless,
pressure from the sinuses due to any inflammatory
process may cause retrograde blood flow into the veins
of the orbit and peri-orbital structures, thus, allowing
the sinus infection to spread haematogenously to the
orbit.
Clinical features
Ocular and orbital involvement in RCOZ is a very
destructive opportunistic infection with severe dreadful
clinical outcome, fatality having been reported in
majority of cases.74 Most of the patients are diabetic
with a recent episode of ketoacidosis, but the condition
may even rarely affect patients with good control of
blood sugar. Clinical conditions such as severe diarrhoea
and renal failure, which often lead to severe metabolic
acidosis can also predispose to such infection.73 In rare
instances, no underlying cause is found. All age groups
are affected. Patients usually come with acute episode
of nasal congestion, rhinitis and facial pain. All patients
are febrile and have markedly elevated white blood cell
count invariably exceeding 20,000/mm3. The infection
progresses very fast and the patient experiences
headache, convulsions and ultimately becomes
comatose. On examination, one finds necrosis and
perforation of the hard palate and necrosis of the nasal
mucosa with thick gangrenous tissue in the nasal cavity
appearing as black eschar. Orbital invasion is heralded
by intense pain. Apical involvement is common, causing
proptosis, visual loss, ophthalmoplegia and sensory loss
along the distribution of trigeminal nerve. A CT scan at
this stage may delineate involvement of paranasal
sinuses, which may guide the clinician in taking decision
Sometimes, in the upper eyelid, the separation between
the insertion of the orbital septum and the upper border
of the tarsus is an unprotected area that may occasionally
55
Nepal Medical College Journal
4-6 weeks. If no renal toxicity and the clinical condition
of the patient improve with AB, then the patient is put
on itraconazole therapy, AB being omitted. Attempts
have also been made to deliver AB directly to the infected
orbital tissue, in the form of daily irrigation and
packing.76
regarding the steps of management. Whether any specific
radiological findings are diagnostic of RCOZ is
controversial, although CT non-enhancement of the
superior ophthalmic artery and vein, which is related to
vasculitis and thrombosis, may represent one such
specific sign. 72-74 However, apart from the clinical
parameters mentioned above, a prompt and accurate
diagnosis of this condition necessitates a reliable and
correct laboratory diagnosis.
In addition, several novel formulations, AB colloidal
dispersion and liposomal Amphotericin-B76,77 have also
been tried with excellent results, keeping in view the
potent toxicity of the conventional drug. However,
controlled trials are needed to assess the efficacy of these
lipid formulations and of the conventional AB in the
therapy of ophthalmic mycoses.
Laboratory diagnosis
Clinical samples: Important clinical samples to be
included are (1) pus/aspirate (2) exudate (3) thick nasal
discharge (4) black eschar from the perforating hard
palate (5) orbitotomy tissue (6) biopsy from the necrosed
tissue. Blood can also be collected for fungal culture.
Other therapeutic options
Earlier studies showed that 100% hyperbaric oxygen at
1 to 3 atms, exerts a fungistatic effect. Hyperbaric oxygen
may decrease tissue hypoxia, enhance oxygen-dependent
cidal mechanism, and decrease tissue acidosis. 76
Exposure to 100% oxygen at 2-2,5 atms for 90-120
minutes every 12 to 24 hours is supposed to be quite
effective.75,78
Processing, culture and identification: Samples should
be transported to the laboratory without any delay. If
delayed, samples should be refrigerated, preferably in
Stuart’s transport medium.74 Blood sample is inoculated
onto the biphasic medium of BHI agar with BHI broth
overlay and incubated at 370C. But the blood culture
bottle should not be refrigerated, even if there is delay
in transportation. Tissue and biopsy samples should be
minced, and not ground in order to avoid the destruction
of any viable fungal elements.
Surgical debridement of the necrotic tissue is another
option for the management. Wide local excision and
debridement of all devitalized oral, nasal, sinus and
orbital tissue with total exenteration of the eye ball may
be performed for the benefit of the patient. However,
this very extensive surgical procedure may not be
practicable all the time. At the same time, orbital
exenteration could sometimes be life-saving in patients
with orbital zygomycosis.79
All samples except the blood is subjected to Gram
staining and 10% KOH wet mount for fungal hyphae.
Demonstration of zygomycetes in the smear of the
necrotic tissue or the thick black eschar from a
symptomatic case is quite diagnostic.75 Part of the sample
can also be stained with hematoxylin-eosin, which serves
as a good adjunct to Gram staining and KOH mount.
For the isolation and identification of the fungal species,
sample should be inoculated onto SDA slants, the rest
of the procedure being the same as described for fungal
keratitis above.33 Blood culture bottles are incubated at
37oC in inclined position (at an angle of 300) for 1 hour
everyday to allow sub- culturing of the organism growing
in the broth onto the agar slant (Castaneda method of
blood culture). Growth of any kind should be identified
according to the standard techniques.33
Influence of fungal species on clinical presentation,
therapeutic management and outcome of infection
Of the all the etiological agents enumerated earlier,
Rhizopus, Mucor and Aspergillus species are exclusively
angio-invasive. Once sinus is involved by the fungus,80
orbit becomes an easy access for these invasive
microbes. The mode of orbital invasion has already been
discussed in the section relating to pathophysiology. The
clinical outcome of orbital cellulitis is invariably fatal
unless appropriate and timely therapeutic measures are
undertaken. This is especially so if there is intra-cranial
spread, which is not unusual in an immuno-compromised
patient. More importantly, Mucor and Rhizopus can give
rise to a fulminant and acutely fatal disease when the
patient is ketoacidotic. In such cases, the prognosis is
very poor.
Treatment
Systemic Amphotericin-B (AB) is the drug of choice.
As has been emphasised earlier, the condition being acute
and fatal, clinical diagnosis and positive smear report
are quite suggestive of starting of therapy without
waiting for the culture report. Conventional AB being
nephrotoxic, it is administered with gradual increase in
the dose each day, starting with 0.25mg/kg/day,
increasing each day by 0.25mg/kg/day till a dosage of 5
mg/kg/day is achieved. It should be given through slow
intravenous drip in 5% dextrose saline with constant
monitoring of blood urea. If there are features of renal
toxicity, systemic AB should be stopped and one can
switch over to oral itraconazole 200mg twice daily for
Although intravenous AB is the best, problem sometimes
arises in managing the cases because of diagnostic
dilemma. The cases with post-septal cellulitis are often
confused clinically with orbital pseudotumors (idiopathic
orbital inflammatory disease) and these individuals may
unnecessarily be kept on steroids. Similarly an encysted
orbital abscess may not always be of fungal origin, or
one may find a rhabdomyosarcoma, being clinically
56
N Nayak
lacrymal puntum.85 Sometimes, the disease may run a
mild and chronic course leading to a complete cicatricial
obliteration of the lacrimal passage. The development
of an encysted mucocele and even the formation of a
fistula on the face are not uncommon.85
confused with orbital infection, in which case
management strategies may be totally different.
In such clinical situations, diagnosis of orbital cellulitis
can always be confirmed by ultrasonography and proper
microbiological investigations. Even if mycological
diagnosis confirms fungal infection of the orbit, still the
managing the case sometimes is difficult. This is owing
to the fact that fungal isolates from deep seated infections
like this often show higher MICs for AB. Thus the
patient might have to be put on a high dose regime i.e.
5mg/kg/day of the drug, with a constant watch on blood
urea and creatinine levels. In case of blood chemistry
abnormality, the drug should be replaced with oral
pasaconazole.81
Laboratory diagnosis
The purulent material from the lacrimal sac is the
samples for microbial study. If regurgitated material is
inadequate, one can opt for draining the contents of the
sac with a sterile syringe and needle. If lacrimal sac is
removed by surgery, then it is bisected for histopathology
and culture. Like a biopsy material, it is then ground,
suspended in sterile buffered saline and used for culture.81
Isolation identification procedure is the same as
described above for fungal keratitis.
DACRYOCYSTITIS
Treatment of dacryocystitis
Mycotic dacryocystitis responds well to topical
administration of 5% Natamycin. Sometimes, alongwith
the topical application, local syringing of the sac with
either Amphotericin-B (1.5 to 8mg/ml) or Nystatin
(100,000 units/ml) solutions may be quite helpful.83 The
recommended surgical procedures adopted are probing
and syringing of the obstruction and dacryocysto-rhinostomy(DCR).84,86
Dacryocystitis is the infection of the lacrimal sac causing
obstruction of nasolacrimal duct (NLD). As a result, the
normal flow of tears through the sac is obstructed.
Pathogenesis
Stagnation of tears due to obstruction and resultant
accumulation of debris in the lacrimal sac, act as the
potential nidus for the organisms to propagate within
the sac causing inflammation, hyperemia, edema and
hypertropy of the mucosal epithelium. Accumulation of
mucoid and mucopurulent exudate cause the sac to dilate,
ultimately leading to a pyocele.82 Thus, dacryocystitis
consists of two components i.e. stasis and infection and
form a vicious cycle. Fungi usually do not cause acute
dacryocystitis. Chronic dacryocystitis is usually due to
a single site of partial or complete obstruction within
the lacrimal sac or within the nasolacrimal duct. Infection
can rarely spread for the neighboring anatomical sites.
Influence of fungal species
In Candida infections, the concretions described above
are yellowish white in color and of rubbery consistency,87
whereas, those due to Aspergillus niger are brown to
black. Recently, it was documented that higher rate of
culture positivity (both fungal as well as bacterial) was
seen, when the discharge was mucoid to mucopurulent.71 Mycotic dacryocystitis invariably responds
satisfactorily to topical antifungals. However, if medical
management fails, surgery is advocated. In spite of the
above mentioned effective antifungal regime, the clinical
outcome of fungal dacryocystitis, especially those due
to Aspergilli or Candida is not quite encouraging. About
40% of the cases managed by medical treatment alone
do recur, whereas around 80% of those who undergo
DCR along with medical treatment get cured.83,84
Etiological agents
Scattered documentations on the fungal cause of
dacryocystitis show varying results. Fungi alone were
found to account for only 5% of cases of acquired
dacryocystitis and for almost 15% of cases of congenital
dacryocystitis.83 A study conducted at our centre revealed
as many as 30.2% of the eyes in congenital
dacryocystitis, Candida albicans and Aspergilli being
the most frequent68 (Table2). However, a recent study
conducted at our centre showed fungi in 5.4% of 112
samples from congenital, and in 4.5% of 110 materials
in acquired dacryocystitis cases84 (Table 3 and 4).
ENDOPHTHALMITIS
Endophthalmitis is an inflammatory reaction of intraocular fluid or tissues. It can be both infectious and noninfectious. Infectious (post-operative, post-traumatic or
endogenous) endophthalmitis is one of the most serious
and vision threatening complications of ophthalmic
surgery.88
Clinical features
Invariably, majority of patients present with epiphora
and discharge. Discharge may be mucoid to
mucopurulent or purulent. Other features which may be
noted are those of conjunctivitis, mucocele or abscess
and lacrimal fistula. On applying pressure on the
lacrimal sac region, there is regurgitation of purulent
material through the lower punctum. Whitish yellow to
brown concretions (dacryoliths) may be seen at the
Etiological agents
There are varying reports on fungal etiology of
endophthalmitis. In post-operative cases, Aspergillus,
Fusarium, Alternaria are reported to be the commonest
agents88-90 whereas in endogenous cases, Aspergillus and
Candida have been incriminated. 88,91 Aspergillus,
Alternaria, Bipolaris, Acremonium, Fusarium are mostly
57
Nepal Medical College Journal
accounted for post-traumatic cases.88,92 Histoplasma
capsulatum var. capsulatum and Coccidioides imitis are
also reported in metastatic endophthalmitis and should
be considered in endemic places and in
immunocompromised patients.93,94 Overall positivity
of fungal isolation in infectious endophthalmitis is
reported to be vary between 11 to 16%.86-88
to decontaminate the globe resulting in significant
reduction in microbial growth, especially that due to
Candida species.98
Clinical features
Fungal endophthalmitis symptoms are similar to those
seen in bacterial one. These include, blurring of vision,
pain, photophobia and red eye.99,100 Important external
signs of inflammation include ciliary congestion,
chemosis, lid oedema, raised intra-ocular pressure,
restrictionof external ocular mobility and proptosis.
Intraocular signs include diminshed visual acuity, altered
pupillary defect, increased pain and redness, hypopyon,
corneal oedma, corneal infiltrate, retinitis, severe
vitreous inflammation with persistent iritis alongwith
visible puff balls and strands. However, there are certain
features which are unique to fungal infection. In Candida
endophthalmitis, for example, there is a creamy, white,
well circumscribed lesion involving the choroid and
retina.91 The lesions may be multiple, are most often
located in the posterior pole and have associated retinal
haemorrhage and perivascular sheathing. The vitreous
may contain yellow-white opacities in the form of ‘string
of pearls’ or fluff balls.88,91 It is also true that, severe
vitreous inflammation with persistent iritis alongwith
whitish fluff balls and strands are quite characteristic of
mycelial fungal endophthalmtis.88 Other findings include
hypopyon and optic nerve edema.
Relevant risk factors
The endogenous endophthalmitis have a variety of
associated pre-morbid conditions that may pre-dispose
them to infetion.88 Most of the fungal endophthalmitis
is associated with immunosuppression. These include
diabetes mellitus, leukaemia, lymphoma, alcoholism,
AIDS, prematurity, IV drug abuse, parenteral
hypheralimentation and long term antibiotic therapy.
Amongst the various traumatic factors which precipitate
post-traumatic endophthalmitis include lens disruption,
intra-ocular foreign body, plant and soil related injury,
injury in rural setting and penetration with an obviously
contaminated device.88
Endophthalmitis following surgery, however, is
influenced by various factors, including pre-operative
conditions, like canaculitis, dacryocystitis and contact
lens use; intra-operative, like profound vitreus loss,
prolonged surgery and inadequate eye lid/conjunctival
disinfection; and post-operative conditions such as
wound leak or dehescences, inadequately buried sutures
following blebs and silicon lenses.91
Laboratory diagnosis
Due to being a vision threatening condition, prompt and
rapid laboratory diagnosis is very important in
endophthalmitis. If there is a delay in the management
and in the administration of appropriate antimicrobial
agents, one may have to go for making a decision for
evisceration of the eye ball. Therefore, when the patient
presents with signs and symptoms suggestive of
infectious endophthalmitis, the best approach is to obtain
intra-ocular sample for microbiological investigation.
Secondly, any post-operative inflammation, which is
more severe than is normally expected after intra-ocular
surgery and is unresponsive to a course of intensive
topical corticosteroids is always suspicious and requires
immediate culture of intra-ocular fluid. Thirdly, presence
of hypopyon after intra-ocular surgery is a strong
indication for vitreous biopsy/culture. In addition,
breaded anterior segment or vitreous opacities with
strands are quite suggestive. In all the above clinical
situations, samples should be collected without delay
so that prompt laboratory diagnosis can be made. The
various clinical samples which are of help include (a)
anterior chamber aspirate (b) vitreous tap (c) vitrectomy/
vitreous biopsy specimen.
68
Endophthalmitis resulting from contact lens use needs
special mention. There seems to be a higher correlation
between fungal contamination of contact lens solution
and development of fungal keratitis and endophthalmitis,
donor corneo scleral rim and post-operative infection.
Although the overall incidence of fungal infection
following penetrating keratoplasty is low (0.16%)7 there
seems to be a higher correlation between fungal
contamination of donor corneocleral rim and postoperative infection, mostly due to C. albicans and other
Candida species7 as well as due to filamentous fungi
such as Exophiala dirmatitidis.95
Thus in most eye banks, cold storage at 4oc is practised.7
Storage medium in most of the cases is tissue culture
medium with antibiotics like gentamicin and
streptomycin or AB, along with Penicillin and
Streptomycin.96,97 During storage, a screening for any
microbiological contamination of donor corneal medium
is always employed. If contamination is detected, those
are discarded. Viable non-contaminated donor corneas
are further incubated for 24 hrs and are used for surgery
if no turbidity is noted. It is debatable if a prolonged
period of warming of the donor button in storage medium
could reduce the incidence of fungal contamination. The
method of disinfection of donor globes may also affect
the rate of contamination of donor corneas. It is
advocated that use of 1% solution of povidone-iodine
Collection and transport of specimens: Anterior
chamber aspirate, though not as helpful as vitreous
sample, is sometimes useful in making a diagnosis.
About 0.2 to 0.3ml of aqueous is collected as described
58
N Nayak
Limitations of fungal culture: There are certain
limitations to culture in establishing an etiological
diagnosis of fungal endophthalmitis. First of all, the
sample size is very small, and organisms being in a fluid
sample are diluted and small in number. So, a little delay
in processing may result in loss of viability of the
organisms. Secondly, fungi are ubiquitous and chances
of laboratory contamination can be a possibility. So, one
should always inoculate more than one fungal culture
media for the same sample. Unlike in case of fungal
keratitis, repeat sampling is not possible in this case for
confirmation of the aetiological agent. Thirdly, review
of the major reports in the literature shows that only
64% of vitreous specimens obtained from eyes with
clinical diagnosis of endophthalmitis are culture
positive.103 Fourthly prior use of antibiotics may yield
negative results in culture and lastly it should always be
remembered that fungi are slow growing organisms and
so there is always a time lag between processing of the
sample and getting a positive culture.
above in the section for keratitis. Vitreous fluid is
collected either by vitreous needle tap or by vitreous
biopsy. Vitreous needle tap is best collected by a sterile
tuberculin syringe and a 22 gauge needle by approaching
the anterior portion of vitreous cavity through pars plana
region. About 0.1 to 0.3ml of fluid is collected by manual
aspiration. At times, due to severe vitreous inflammation,
it is not possible to collect vitreous aspirate by simple
needle tap. Hence, vitreous biopsy is the only alternative.
In this procedure, vitreous is cut with a vitrectomy
cutting/aspirating probe, which is attached to a tuberculin
syringe and needle. Vitreous cavity is reached through
pars plana approach. Nearly 0.2 to 0.3ml material is
obtained by manual aspiration into the syringe during
the activation of the cutting mechanism. The specimen
is sent to the laboratory, preferably undiluted to increase
the yield.
As mentioned earlier, the aqueous and/or vitreous
specimens are usually sent to the laboratory in the same
syringes used for collection. If the laboratory is not
located nearby the culture media need be inoculated in
the operating room itself. If bedside inoculation is not
possible due to some reason and delay in transport is
apprehended, then the sample should not be refrigerated.
It is preferable to preserve the sample in a 25oC in BOD
incubator, till it is processed. Both aqueous and vitreous
cultures are recommended in endophthalmitis. 101,102
However, the sensitivity of the culture is increased with
the vitreous rather than with the aqueous alone.102
Cultures of external ocular surfaces are not of value
except in the presence of an open wound or a leaking
bleb. The advent of therapeutic vitrectomy has provided
an alternative modality of obtaining vitreous in
endophthalmitis.
Molecular methods: Considering the limitations of
culture methods, molecular methods such as PCR in the
rapid diagnosis of fungal endophthalmitis seems quite
promising. Most of the PCR techniques use the multi
copy gene targets such as the fungal ribosomal DNA
gene cluster.105 The ribosomal DNA (rDNA) gene is a
tandem array of at least 50-100 copies in the haploid
genome of all fungi. It comprises the small subunit rDNA
(18S) gene, the 5.8 S gene and the large subunit rDNA
(28S) gene.35 Separating the 18S and 5.8S is ITS1 region
and 5.8S and 28S is ITS2 region, which are called
internal transcribed spacer regions. Between each of
these set of transcripts is the intergenic spacer region
(IGS). Any component of this gene cluster can be
selected as a target for PCR. Whereas rDNA genes
(coding regions) are highly conserved, the ITS regions
are moderately variable and the IGS region is highly
variable between different fungi.106 So this allows the
designing of universal primers based on the conserved
regions, which will amplify a certain region of the rDNA
gene cluster from a large number of fungal species, as
well as species specific primers/probes based upon the
variable regions, that can be used to identify the species.
At least 16 Candida and 5 Aspergillus species specific
probes have been designed based upon this principle.26,107
If a two or three port vitrectomy is done for collecting
vitreous biopsy, then vitrectomy cassette fluid is the ideal
sample for culture. The sensitivity of culture of vitretomy
casstte fluid, passed through a 0.2u Millipore filter, is
reportedly higher than vitreous biopsy culture obtained
by a needle and syringe.102
Processing and identification of fungi: The procedure
of microscopic examination and culture is the same as
used routinely for any other ocular specimen described
above. Smear examination though provide a rapid
diagnosis103 is very less sensitive. The commonly used
Gram’s and Giemsa’s staining techniques have 60% and
41% sensitivities respectively.104
Anand et al108 recently studied 27 intra-ocular specimens
from 22 cases of suspected fungal endophthalmitis, by
conventional microscopy and culture as well as by PCR
assay, for the detection of fungi. None of the controls
(non-infective intra-ocular disorders) were positive. PCR
detected fungi in more number of samples, which were
negative by the conventional method. Average time
required for culture was 10 days, whereas PCR needed
only 24 hours. In another study, PCR was found to be
more sensitive and a rapid diagnostic tool compared with
the conventional mycologic methods in the diagnosis
Apart from conventional culture, the membrane filter
system is advocated for better yield of the microorganism.103 The vitrectomy specimen is first processed
by passing through a 0.2u membrane filter. The filter is
then removed aseptically and cut into segments for direct
inoculation onto the culture media. Processing of both
vitreous biopsy and vitrectomy cassette fluid by this
technique provides greater sensitivity.104
59
Nepal Medical College Journal
CONCLUSION
Ocular fungal infections are increasingly gaining importance in
clinical practice due to modern therapeutic management facilities
and increasing number of immunocompromised patients. Thus
our research needs to focus entirely on improvement in diagnostic
techniques, development of new antifungal agents and
standardization of their sensitivity testing and a better
understanding of the pathogenesis of the conditions.
of fungal endophthalmitis.109 Hidalgo et al,110 in yet
another study of Candida endophthalmitis noted PCR
positivity in all the four patients of suspected
endophthalmitis, by using species-specific PCR in the
vitreous samples, while the culture of vitreous was
negative in two specimens.
Thus, it appears that PCR is a highly sensitive and rapid
method to diagnose fungal endophthalmitis. It is a very
useful laboratory tool, especially in the tropical countries,
where incidence of fungal eye infections is quite high.
The much more rapidity of PCR as compared to culture
will certainly help the Ophthalmologist in planning the
effective and quick therapeutic measures. Its paramount
effectiveness in the rapidity and accuracy in diagnosis
will ultimately have a major impact on improvement in
the prognosis of patients with fungal endophthalmitis.
This is especially true for post-operative endophthalmitis
following cataract surgery, which is the commonst form
of fungal endophthalmitis, where early diagnosis is very
important for effective management of patients in order
to avoid severe and vision threatening ocular morbidity.
According to a recently conducted study in India,111 it
was observed that PCR for detection of fungal DNA
was found to be a rapid and a more sensitive method
compared to conventional culture method in the early
diagnosis of post-operative endophthalmitis. In addition,
further areas of interest include identification of fugnal
species using species specific primers.106,112,113 for the
detection of C. albicans, A. fumigatus, F. solani and Al.
infectoria114 in intraocular samples as well as in corneal
scrapings. This would ultimately have a major impact
on improvement in the prognosis of the subject not only
with fungal endophthalmitis but with other ocular fungal
infections as well.
REFERENCES
1. Srinivasan R, Kanungo R, Goyal JL. Spectrum of oculomycosis
in South India. Acta Ophthalmol 1991; 69: 744-9.
2. Abad JC, Foster CS. Fungal keratitis. Int’l Ophthalmol Clin
1996; 36: 1-15.
3. Agarwal V, Biswas J, Madhavan HN et al. Current
perspectives in infectious keratitis. Indian J Ophthalmol 1994;
42: 171-92.
4. Gunawerdena SA, Ranasinghe KP, Arseceuleratne SN,
Scimon CR, Ajello L. Survey of mycotic and bacterial keratitis
in Sri Lanka. Mycopathologia 1994; 127: 77-81.
5. Hagan M, Wright E, Newman M, Dolin P, Johnson G. Causes
of suppurative keratitis in Ghana. Brit J Ophthalmol 1995;
79: 1024-8.
6. Sharma S, Srinivasan M, George C. The current status of
Fusarium species in mycotic keratitis in South India. Indian
J Med Microbiol 1993; 11: 140-7.
7. Keyhani K, Seedor JA, Shah MK, Terraciano AJ Rittervand
DC. The incidence of Fungal Keratitis and Endophthalmitis
following penetrating keratoplasty. Cornea 2005; 24: 288-91.
8. Harris DJ, Stulting RD, Wring G et al. Late bacterial and fungal
keratitis after corneal transplantation. Ophthalmol 1998; 95:
1450-7.
9. Vajpayee RB, Ray M, Panda A et al. Risk factors of pediatric
presumed microbial keratitis: a case control study. Cornea
1999; 18: 565-9.
10. Panda A, Sharma N, Das G, Kumar N, Satpathy G. Mycotic
keratitis in children : epidemiologic and microbiologic
evaluation. Cornea 1997; 16: 295-9.
Influence of fungal species on clinical presentation,
therapeutic management and outcome of infection
11. Rosa Jr RH, Miller D, Alfonso EC. The changing spectrum
of fungal keratitis in South Florida. Ophthalmology 1994;
101: 1005-13.
Endophthalmitis due to Candida species is well
documented, both as a consequence of fungemia and as
a result of dissemination from endogenous source in an
immunocompromised indivisual. Intra-ocular signs and
symptoms such as diminished visual acuity, severe
vitreous inflammation with persistent iritis, whitish puff
balls and strands are more commonly seen in
endophthalmitis due to Candia and Aspergilli. In
addition, infection due to C. albicans may result in
choroidal neovascularisation, which is a potential cause
of late visual loss in patients who have had sepsis and
endogenous chorioretinitis due this organism.
12. Houang E, Lam D, Fan D, Seal D. Microbial keratitis in Hong
Kong, relationship to climate, environment and contact-lens
disinfection. Trans Roy Soc Trop Med Hyg 2001; 95: 361-7.
13. Fusarium keratitis-multiple states. Morb Mortal Weekly
Report 2006; 55: 400-1.
14. Tanure MA, Cohen EJ, Grewal S, Rapuano CJ, Laibson PR.
Spectrum of fungal keratitis at Wills Eye Hospital,
Philadelphia, Pennsylvania. Cornea 2000; 19: 307-12.
15. Gopinathan U, Garg P, Fernandes M, Sharma s, Athamanathan
S, Rao GN. The epidemiological features and laboratory
results of fungal keratitis: a 10 year review at a referral eye
care center in South India. Cornea 2002; 21: 555-9.
The therapeutic implications of the above clinical entity
are alarming. Species of Candida other than C. albicans
are reportedly showing in vitro resistance to Fluconazole.
In addition, C. tropicalis is intrinsically resistant to many
azole compounds. Thus, newer azoles like voriconazole
and posaconazole are worth trying.52
16. Srinivasan M, Ganzales CA, George C et al. Epidemiology
and aetiological diagnosis of corneal ulceration in Madurai,
South India. Brit J Ophthalmol 1997; 81: 965-71.
17. Chowdhury A, Singh K. Spectrum of fungal keratitis in North
India. Cornea 2005; 24: 8-15.
18. Laspina F, Samudio M, Cibils D et al. Epidemiological
60
N Nayak
Alternaria alternata. Amer J Ophthalmol 2002; 33: 398-9.
characteristic of microbiological results on patients with
infectious corneal ulcers: a 13 year survey in Paraguay.
Graefes Arch Clin Exp Ophthalmol 2004; 242: 204-9.
37. Gaudio PA, Gopinanthan U, Sangwan V, Hughes TE.
Polymerase chain reaction based detection of fungi in infected
corneas. Brit J Ophthalmol 2002; 86: 755-60.
19. Basak SK, Basak S, Mohanta A, Bhowmick A.
Epidemiological and microbiological diagnosis of suppurative
keratitis in gangetic West Bengal, Eastern India. Indian J
Ophthalmol 2005; 53: 17-22.
38. Behrens-Baumann W. Topical Antimycotics in
Ophthalmology. Ophthalmologica 1997; 21 (Suppl 1): 33-8.
39. Beggs WH. Mechanism of synergistic interaction between
Amphotericin B and Flucytosine. J Antimirob Chemother
1986; 17: 403-4.
20. Wong TY, Ng TP, Fong KS, Tan DTH. Risk factors and
clinical outcome between fungal and bacterial keratitis. A
comparative study. CLAO J 1997; 23: 275-81.
40. Viviani MA. Flucytosine-what is its future? J Antimicrob
Chemother 1995; 35: 241-4.
21. Zimmerman LE. Keratomycosis.Surv Ophthalmol 1963; 8:
1-25.
41. Pflugfelder SC, Flynn HW, Zwickey TA et al. Exogenous
fugnal endophthalmitis. Ophthalmol 1988; 95: 19-30.
22. Wilhelmus KR, Robinson NM, Font RA, Hamil MB, Jones
DB. Fungal keratitis in contact lens wearers. Amer J
Ophthalmol 1988; 106: 708-14.
42. Fitzsimons R, Peters AI. Miconazole and ketoconazole as
satisfactory first-line treatment for kerato-mycosis. Amer J
Ophthalmol 1986; 101: 605-8.
23. Naumann G, Green WR, Zimmerman LE. Mycotic keratitis. A
histopathological study of 73 cases. Amer J Ophthalmol 1967; 64:
668-82.
43. Mohan M, Panda A, Gupta SK. Management of human
keratomycosis with miconazole. Aust N Z J Ophthalmol
1989; 17: 295-7.
24. Kaufman HE, Wood RM. Mycotic Keratitis. Amer J
Ophthalmol 1965; 59: 993-1000.
25. Gingrich WD. Kertomycosis. J Amer Med Assoc 1962; 179:
602-8.
44. Komadina TG, Wilkes TD, Shock JP et al. Treatment of
Aspergillus fumigatus keratitis in rabbits with oral and topical
ketoconazole. Amer J Ophthalmol 1985; 99: 476-9.
26. Klotz SA, Penn CC, Negvesky GJ, Batrus SI. Fungal and
parasitic infection of the eye. Clin Microbiol Rev 2000; 13:
662-85.
45. Hemady RK, Foster CS. Intra-ocular penetration of
ketoconazole in rabbits. Cornea 1992; 11: 329-33.
46. Oji EO. Ketoconazole: A new imidazole agent has both
prophylactic potential and therapeutic efficacy in
keratomycosis in rabbits. Int’l Ophthalmol 1982; 5: 163-7.
27. Jacob P, Gopinathan U, Sharma S, Rao GN. Calcium alignate
swab versus Bard Parker blade in the diagnosis of microbial
keratiits. Cornea 1995; 14: 360-4.
47. Behrens-Baumann W, Klinge R, Richel R. Topical flucanazole
for experimental Candida keratitis in rabbits. Brit J
Ophthalmol 1990; 74: 40-2.
28. Rao Narasing A. A laboratory approach to rapid diagnosis of
ocular infections and perspects for the future. Amer J
Ophthalmol 1989; 107: 283-90.
48. Rajasekaran J, Thomas PA, Kalavathy CM, Joseph PC,
Abraham DJ. Itraconazole therapy for fungal keratitis. Indian
J Ophthalmol 1987; 35: 157-60.
29. Vajpayee RB, Angra SK, Sandramauli S, Honavar SG,
Chhabra VK. Laboratory diagnosis of keratomycosis :
comparative evaluation of direct microscopy and culture
results. Ann Ophthalmol 1993; 25: 68-71.
49. Coad CT, RobinsonNM, Weilhelmus KR. Antifungal
sensitivity testing for equine keratomycosis. Amer J Vet Res
1985; 46: 676-8.
30. Jones DB. Initial therapy of suspected microbial corneal ulcers
II. Specific antibiotic therapy based on corneal smears. Surv
Ophthalmol 1979; 24: 97-116.
50. Marangon FB, Miller D, Giacore JA, Alfonso EC. Invitro
investigation of voriconazole susceptibility for keratitis and
endophthalmitis fungal pathogens. Amer J Ophthalmolol
2004; 137: 820-5.
31. Arora R, Venkateswaralu K, Mahajan VM. Keratomycosis –
a retrospective histopathological and microbiologic analysis.
Ann Ophthalmol 1988; 20: 306-13.
51. Sponset W, Chen N, Dang D et al. Topical voriconazole as a
novel treatment for fungal keratitis. Antimicrob Agents
Chemother 2006; 50: 262-8.
32. Marines HM, Osato MS, Font RL. The value of calcofluor
white in the diagnosis of mycotic and Acanthamoeba
infections of the eye and ocular adenxa. Opthalmol 1987;
94: 23-6.
52. Ozbek Z, Kang S, Sivalingam J, Rapuano CJ, Cohen EJ,
Hammersmith KM. Voriconazole in the management of
Alternaria keratitis. Cornea 2006; 25: 242-4.
33. Rippon JW. Laboratory Mycology Section II Culture
methods,media,stains and serologic procedures.In: Rippon JW
eds. Medical Mycology: The pathogenic fungi and the pathogenic
Actinomycetes, 2nd edn. WB Saunders 1982: 772-95.
53. Goldblum D, Fruch BE, Sarra GM, Katsoulis K, Zimmerli S.
Topical Caspofungin for treatment of keratitis caused by
Candida abicans in a rabbit model. Antimicrob Agetns
Chemother 2005; 49: 1359-63.
34. Rippon JW. Candidiasis and the pathogenic yeasts.In Rippon JW
eds.: Medical Mycology: The pathogenic fungi and the pathogenic
Actinomycetes, 2nd edn, WB Saunders 1988:536-81.
54. Panda A, Ahuja R, Biswas NR, Satpathy G, Khokhar S. Role of
.02% polyhexamethyl biguanide and 1% puvidone iodine in
experimental Aspergillus keratitis. Cornea 2003; 22: 138-41.
35. Chen SC, Halliday CL, Meyer W. A review of nucleic acid
diagnostic tests for systemic mycoses with an emphasis on
polymerase chain reaction-based assays. Med Mycol 2002;
40 : 333-57.
55. Wilhelmus KR, Jones DB. Curvularia keratitis. Trans Am
Ophthalmol Soc 2001; 99: 111-32.
36. Ferrer C, Munoz G, Alio JL, Abad JL, Colon F. Polymerase
chain reaction diagnosis in fungal keratitis caused by
56. Kim JS, Kim JC, Hahn TW, Park WC. Amniotic membrane
transplantation in infectious corneal ulcer. Cornea 2001; 20:
61
Nepal Medical College Journal
720-6.
mellitus. Med Mycol 2006; 44: 335-42.
75. Ribes JA, Vanover–Sams CL, Baker DJ. Zygomycetes in
human disease. Clin Microbiol Rev 2000; 13: 236-301.
57. Frucht-Pery J, Mor M, Evron R, Lewis A, Zauberman H.
The effect of the ArF excimer laser on Candida albicans in
vitro. Gracfes Arch Clin Exp Ophthalmol 1993; 231: 413-5.
76. Khoo SH, Band J, Denning DW. Administering Amphotericin
B–a practical approach. J Antimicrob Chemother 1994; 33:
203-13.
58. Jones BR. Principles in the management of oculomycosis.
Amer J Ophthalmol 1975; 79: 719-51.
77. Walker S, Tailor SAN, Lee M et al. Amphotericin B in lipid
emulsions: stability, compatibility and in vitro antifungal
acitiviy. Antimicrob Agents Chemother 1998; 42: 762-6.
59. Vemuganti GK, Garg P, Gopinathan U et al. Evaluation of agent
and host factors in progression of mycotic keratitis : A histologic
and microbiologic study of 167 corneal buttons. Ophthalmol
2002; 109: 1538-46.
60. Israele V, Nelson JD. Periorbital and orbital cellulitis. Pediatr
Infect Dis J 1987; 6: 404-10.
78. Ferguson BJ,Mitchell TG,Moon R,Camporesi EM,Formin J.
Adjunctive hyperbaric oxygen for the treatment of Rhinocerebral mucormycosis. Rev Infect Dis 1988; 10: 551-9.
61. Bloom PA, Laidlaw DA, Easty DL, Warnock DW. Treatment
failure in case of fungal keratitis caused by Pseudallescheria
boydii. Brit J Ophthalmol 1992; 76: 367-8.
79. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors
in rhino-orbital cerebral mucormycosis. Surv Ophthalmol 1994;
39: 3-22.
62. Ozkurt Y, Oral Y, Kuleckei Z, Benzonana N, Ustaoglu R,
Dogan OK. Pseudallescheria boydii keratitis. J Paed
Ophthalmol Strabismus 2006; 43: 114-5.
80. Lessner A, Stern GA. Preseptal and orbital cellulitis. Infect
Dis Clin North America 1972; 6: 933-52.
81. Rutor T,Cockerham KP.Periorbita zygomycosois
(Mucormycosis) trated with posaconazole.Amer J
Ophthalmol 2006; 142:187-8..
63. Pujol I, Guarro J, Sala J and Riba MD. Effects of incubation
temperative, inoculum size, and time of reading on broth
microdilution susceptibility test results for Amphotericin B
against Fusarium. Antimicrob Agents Chemother 1997; 41:
808-11.
82. Traquair HM. Chronic dacryocystitis, its causation and
treatment. Arch Ophthalmol 1941; 26: 165-80.
83. Ghose S, Mahajan VM. Microbiology of congenital
dacryocystitis:its clinical significance. J Ocul Ther Surg
1985;4:54-57.
64. Espinel-Ingroff A, Barchiese F, Cuenca – Estrella M et al.
International and multicenter comparison of EUCAST and
CLSI M27-a2 broth microdilution methods for testing
susceptibility of Candida species to flucanazole, itraconazole,
posaconazole and voriconazole. J Clin Microbiol 2005; 43:
3884-9.
84. Ghose S, Jha RK, Nayak N et al. Current microbial correlates
of the eye and nose in Dacryocystitis- their clinical
significance. Proceedings All India Ophthalmol Soc Conf
2005: 437-9.
85. Behrens–Baumann W. Mycoses of the eye and its adnexa.
Dev Ophthalmol 1999; 32: 27-107.
86. Katowitz J. Timing of initial probing and irrigation in
congenital nasolacrimal duct obstruction. Ophthalmol 1987;
94: 698-705.
87. Boruchoff SA, Boruchoff SE. Infections of the lacrimal
system. Infect Dis Clin North America 1992;6:925-933
88. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis.
Surv Ophthalmol 1998; 43: 193-224.
89. Kunimoto DY, Das T, Sharma S et al. Microbiologic spectrum
and susceptibility of isolates: Part I. Post operative
endopthalmitis. Amer J Ophthalmol 1999; 128: 240-2.
90. Anand AR, Therese KL, Madhavan HN. Spectrum of
aetiological agents of post-operative endophthalmitis and
antibiotic susceptibility of bacterial isolates. Indian J
Ophthalmol 2000; 48: 123-8.
65. Roma, Kaushal Anju, Roy P, Singh H. Antifungal
susceptibility patern of non-albicans Candida species and
distribution of species isolated form candidaemia cases over
a 5 year period. Indian J Med Res 1996; 106: 171-6.
66. Nguyen MH, Yu CY. Influence of incubation time, inodulum
size, and glucose concentration on spetrophotometric endpoint
: determinants of Amphotericin B, fluconazole and
itraconazole. J Clin Microbol 1999; 37: 141-5.
67. Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M.
Risk factors and Rx outcome in fungal keratitis.
Ophthalmology 2006; 113: 526-30.
68. Rosenberg KD, Flynn HW Jr., Alfonse EC, Miller D.
Fusarium endophthalmitis following keratitis associated with
contact lens. Oph Surg Laser Imaging 2006; 37: 310-3.
69. Jackson K, Barker SR. Clinical implications of orbital
cellulitis. Laryngoscope 1986; 96: 568-74.
91. Samiy N, D’Amico DJ. Endogenous fungal endophthalmitis.
Int’l Ophthalmol Clin 1996; 36: 147-62.
70. Chandler JR, Langenbrunner DJ, Stevens ER. The
pathogenesis of orbital complications in acute sinusitis.
Laryngoscope 1970; 80: 1414-28.
92. Kunimoto DY, Das T, Sharma S et al. Microbiologic spectrum
and susceptibility of isolates: Part II. Post traumatic
endophthalmitis. Amer J Ophthalmol 1999; 128: 242-4.
71. Gellady AM, Shulman ST, Ayrab EM. Peri-orbital and orbital
celluliis in children. Pediatrics 1978; 61: 272-7.
93. Gonzales CA, Scott IU, Chowdhury NA et al. Endogenous
endophthalmitis caused by Histoplasma capsulatum
var.capsulatum: a case report and literature review.
Ophthalmol 2000; 107: 725-9.
72. Mills RP, Kartush JM. Orbital wall thickness and the spread
of infection from the paranasal sinuses. Clin Otolaryngol
1985; 10: 209-16.
73. Rippon JW.Mucormycosis.In: Rippon JW eds. Medical
Mycology:The pathogenic fungi and the pathogenic
Actinomycetes 2nd eds., WB Saunders 1982: 615-40.
94. Culter JE, Binder PS, Paul TO, Beamis JE. Metastatic
Coccidioidal endophthalmitis.Arch Ophthalmol 1978; 96:
689-91.
74. Chakrabarti A, Das A, Mandal J et al. The rising trend of
invasive zygomycosis in patients with uncontrolled diabetes
95. Benaoudia F, Assouline M, Pouliquen Y, Bouvet A, Gueho
62
N Nayak
E. Exophiala (Wangiella) dermatitidis keratitis after
keratoplasty. Med Mycol 1999; 37: 53-6.
106. Reiss E, Tanaka K, Bruker G et al. Molecular diagnosis
and epidemiology of fugnal infections. Med Mycol 1998;
36 (suppl 1): 249-57.
96. Merchant A, Zacks CM, Wilhemus K et al. Candidal
endophthalmitis afterkeratoplasty. Cornea 2001; 20: 226-9.
107. Elie CM, Lott TJ, Reiss E, Morrison CJ. Rapid
identification of Candida species with species specific DNA
probes. J Clin Microbiol 1998; 36: 3260-5.
97. Mass-Reijs J, Pels E, Tullo AB. Eye banking in Europe 19911995. Acta Ophthalmol Scand 1997; 75: 541-3.
108. Anand AR, Madhavan HN, Sudha NV, Therese KL.
Polymerase chain reaction in the diagnosis of Aspergillus
endophthalmitis. Indian J Med Res 2001; 114: 133-40.
98. Ainley R, Smith B. Fungal flora of the conjunctival sac in healthy
and diseased eyes. Brit J Ophthalmol 1965; 49: 505-15.
99. Michaelson PE, Stark W, Reeser F, Green WR. Endogenous
Candida endophthalmitis: report of 13 cases and 16 from the
literature. Int’l Ophthalmol Clin 1971; 11: 125-47.
109. Anand AR, Madhavan HN, Neelam V, Therese KL. Use of
polymerase chain reaction in the diagnosis of fungal
endophthalmitis. Ophthalmol 2001; 108: 326-30.
100. Griffin JR, Pettit TH, Fishman LS, Foss RY. Blood borne
Candida endophthalmitis: a clinical and pathologic study
of 21 cases. Arch Ophthalmol 1973; 89: 450-6.
110. Hidalgo JA, Alangaden GJ, Eliott D et al. Fungal
endophthalmitis : Diagnosis by detection of Candida
albicans DNA in intra-ocular fluid by use of a speciesspecific polymerase chain reaction assay. J Infect Dis 2000;
181: 1198-201.
101. Allansmith MR, Skaggs C, Kimura SJ. Anterior chamber
paracentesis. Diagnostic value in postoperative
endophthalmitis. Arch Ophthalmol 1970; 84: 745-8.
111. Tarai B, Gupta A, Ray P. Shivaprakash MR, Chakrabarti
A. Polymerase chain reaction for early diagnosis of postoperative fungal endophthalmitis. Indian J Med Res 2006;
123: 671-8.
102. Koul S, Philipson A, Arvidson S. Role of aqueous and
vitreous culture in diagnosing infectious endophthalmitis
in rabbits. Acta Ophthalmol 1990; 68: 466-9.
112. Jaeger EM, Caroll NM, Choudhury S et al. Rapid detection
and identification of Candida, Aspergillus and Fusarium
species in ocular samples using nested PCR. J Clin
Microbiol 2000; 38: 2902-8.
103. Das T, Dogra MK, Gopal L et al. Postsurgical endophthalmitis:
Diagnosis and management. Indian J Ophthalmol 1995; 43:
103-16.
104. Sharma S, Jalali S, Adiraju MV, Gopinathan U, Ds T.
Sensitivity and predictability of vitreous cytology, biopsy
and membrane filter culture in endophthalmitis. Retina
1996; 16: 525-9.
113. Ferrer C, Montero J, Alio JL et al. Rapid molecular
diagnosis of posttraumatic keratitis and endophthalmitis
caused by Alternaria infectoria. J Clin Microbiol 2003;
41: 3358-60
105. Odds FC. Reflections on question: What does molecular
mycology have to do with the clinician treating the patient?
Med Mycol 2003; 41: 1-6.
114. ManciniN, Ossi CM, Perotti M et al. Direct sequencing of
Scedosporium apiospermum DNA in the diagnosis of a case
of keratitis. J Med Microbiol 2005; 54: 897-900.
63